Hypertrophic cardiomyopathy vs athlete's heart

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 151-155

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ATHLETE; ECHOCARDIOGRAPHY; EDITORIAL; FAMILY HISTORY; GENETIC ANALYSIS; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; OXYGEN CONSUMPTION; PREVALENCE; PRIORITY JOURNAL; SUDDEN DEATH; TISSUE DOPPLER IMAGING; TRAINING;

CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; SPORTS;

EID: 57549083788     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.015     Document Type: Editorial

References (51)

1. Maron B.J. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 91 (2005) 1380-1382
2. Cheng T.O. The evolution of cardiology in China. Cardiothoracic surgery in China: past, present and future (2007), The Chinese University of Hong Kong, Hong Kong 204-305
3. Tung C.L., Hsieh C.K., Bien C.W., and Dieuaide F.R. The heart in ricksha pullers. A study of the effect of chronic exertion on the cardiovascular system. Am Heart J 10 (1934) 79-100
4. White P.D. Heart disease. 4th Edition (1951), MacMillan Co., New York 612
5. Watkins H., Seidman C.E., MacRae C., Seidman J.G., and McKenna W. Progress in familial hypertrophic cardiomyopathy: molecular genetic analyses in the original family studied by Teare. Br Heart J 67 (1992) 34-38
6. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20 (1958) 1-8
7. Pelliccia A., Maron B.J., Spataro A., Proschan M.A., and Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained athletes. N Engl J Med 324 (1991) 295-301
8. Maron B.J., Gottdiener J.S., and Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48 (1981) 418-428
9. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
10. Spirito P., Pelliccia A., Proschan M., et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 74 (1994) 802-806
11. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
12. Maron B.J., Pelliccia A., and Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 91 (1995) 1596-1601
13. Pelliccia A., Culasso F., Di Paolo F.M., and Maron B.J. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130 (1999) 23-31
14. Cheng T.O. Hypertrophic cardiomyopathy evolving into a hypokinetic and dilated left ventricle: coronary embolization as a probable pathogenetic mechanism. Clin Cardiol 13 10 (1990) A31
15. Pelliccia A., Avelar E., De Castro S., and Pandian N. Global left ventricular shape is not altered as a consequence of physiologic remodeling in highly trained athletes. Am J Cardiol 86 (2000) 700-702
16. Shapiro L.M., and McKenna W.J. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 2 (1983) 437-444
17. Pelliccia A., Maron B.J., Di Paolo F.M., et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 46 (2005) 690-696
18. Nistri S., Olivotto I., Betocchi S., et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 98 (2006) 960-965
19. Cheng T.O. Prompt squatting and systolic murmurs. Am Heart J 77 (1969) 433
20. Cheng T.O. Diagnostic tips in idiopathic hypertrophic subaortic stenosis. Hosp. Physician 18 (1982) 36
21. Cheng T.O. Atypical HCM signs. Phys Sportsmed 23 7 (1995) 21
22. Cheng T.O. Case of the month/cardiology: a 30-year-old athlete fell by syncope. Cortlandt Forum 11 4 (1998) 217-229
23. Cheng T.O. Valsalva maneuver is not a held deep inspiration. Am J Cardiol 88 (2001) 1219-1220
24. Maron M.S., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
25. Shah J.S., Tome Esteban M.T., Thaman R., et al. Prevalence of exercise induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 94 (Oct. 21 2008) 1288-1294
26. Vaglio Jr. J.C., Ommen S.R., Nishimura R.A., Tajik A.J., and Gersh B.J. Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with a latent obstruction. Am Heart J 156 (2008) 342-347
27. Griffet V., Guérard S., Galoisy-Guibal L., Caignault J.R., Bernard F., and Brion R. Normal values of the peak early diastolic Ea using myocardial tissue Doppler in 100 elite athletes. Arch Mal Coeur Vaiss 100 (2007) 809-815
28. Pelliccia A., and Maron B.J. The athlete's heart, ECG, and differential diagnosis with hypertrophic cardiomyopathy and other cardiomyopathies. In: Maron B.J. (Ed). Diagnosis and management of hypertrophic cardiomyopathy (2004), Blackwell Futura, Malden, MA 367-381
29. Krieg A., Scharhag J., Kindermann W., and Urhausen A. Cardiac tissue Doppler imaging in sports medicine. Sports Med 37 (2007) 15-30
30. Zoncu S., Pelliccia A., and Mercuro G. Assessment of regional systolic and diastolic wall motion velocities in highly trained athletes by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 15 (2002) 900-905
31. D'Andrea A., D'Andrea L., Caso P., Scherillo M., Zeppilli P., and Calabrò R. The usefulness of Doppler myocardial imaging in the study of athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23 (2006) 149-157
32. D'Andrea A., Caso P., Severino S., et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1311-1318
33. Rajiv C., Vinereanu D., and Fraser A.G. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol 19 (2004) 430-436
34. Nagueh S.F., McFalls J., Meyer D., et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 108 (2003) 395-398
35. Urheim S., Edvardsen T., Torp H., Angelsen B., and Smiseth O.A. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
36. Voigt J.U., Lindenmeier G., Werner D., et al. Strain rate imaging for the assessment of preload-dependent changes in regional left ventricular diastolic longitudinal function. J Am Soc Echocardiogr 15 (2002) 13-19
37. Cheng T.O. Hypertrophic cardiomyopathy in China: from bench to bedside. Int J Cardiol 130 (Nov. 12 2008) 121-124
38. Kato T.S., Noda A., Izawa H., et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110 (2004) 3808-3814
39. Richand V., Lafitte S., Reant P., et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 100 (2007) 128-132
40. Sharma S., Elliott P.M., Whyte G., et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 36 (2000) 864-870
41. Anastasakis A., Kotsiopoulou C., Rigopoulos A., et al. Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes. Heart 91 (2005) 1477-1478
42. Godon P, Griffet V, Vinsonneau U, et al.: Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide. Int J Cardiol, in press.
43. White P.D. Heart disease. 4th Edition (1951), MacMillan Co., New York 611
44. Maron B.J., Pelliccia A., Spataro A., and Granata M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 69 (1993) 125-128
45. Pelliccia A., Maron B.J., De Luca R., Di Paolo F.M., Spataro A., and Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 105 (2002) 944-949
46. Maron B.J., Seidman J.G., and Seidman C.E. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2125-2132
47. Basavarajaiah S., Wilson M., Whyte G., Shah A., McKenna W., and Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes. J Am Coll Cardiol 51 (2008) 1033-1039
48. Ma J.Z., Dai J., Sun B., Ji P., Yang D., and Zhang J.N. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death in China. J Sci Med Sport 10 (2007) 227-233
49. Magalski A., Maron B.J., Main M.L., et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 51 (2008) 2250-2255
50. Bssavarajaiah S., Boraita A., Whyte G., et al. Ethnic differences in left ventricular remodeling in highly-trained athletes. Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 51 (2008) 2256-2262
51. Pelliccia A. Differences in cardiac remodeling associated with race. Implications for pre-participation screening and the unfavorable situation of black athletes. J Am Coll Cardiol 51 (2008) 2263-2265